Stacey is a QC microbiologist with 20 years of direct laboratory experience in pharmaceutical quality control. Through her years of method and process development, Stacey focuses on bringing robust quality processes to the laboratory through continual improvement and change in order to deliver safe and effective products to patients. She earned her BS in Biological Sciences from Wichita State University and Master of Science degree from Friends University. Stacey began her career in QC and R&D microbiology with CMO, Hospira (now Pfizer), working with new and modern parenteral medicines. Having worked in both contract manufacturing and laboratory services, she has a broad background in laboratory testing, including environmental monitoring, aseptic processing, microbial identification, endotoxin testing, and rapid microbial detection.
Regulatory Changes: USP 73 & 1071 Updates at a Glance
The latest chapters of USP <73> and <1071> introduce key updates impacting sterility testing and rapid microbiological methods (RMMs). Understanding these changes is crucial for compliance and optimizing your microbial testing strategy. Our expert guide breaks down what’s new and how Celsis® can help you stay compliant and efficient.
Explore the Guide
Webinar: Accelerate Sterility Testing with USP <73>
In this webinar, Labor LS and Charles River industry experts discuss how ATP-bioluminescence is shaping the future of short-life products. Explore real-world insights and validation strategies.
Watch the Replay